143 related articles for article (PubMed ID: 7678248)
1. Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101.
Jones JI; Busby WH; Wright G; Smith CE; Kimack NM; Clemmons DR
J Biol Chem; 1993 Jan; 268(2):1125-31. PubMed ID: 7678248
[TBL] [Abstract][Full Text] [Related]
2. Human IGFBP-1 is phosphorylated on 3 serine residues: effects of site-directed mutagenesis of the major phosphoserine.
Jones JI; Busby WH; Wright G; Clemmons DR
Growth Regul; 1993 Mar; 3(1):37-40. PubMed ID: 7683525
[TBL] [Abstract][Full Text] [Related]
3. Identification of the major sites of phosphorylation in IGF binding protein-3.
Hoeck WG; Mukku VR
J Cell Biochem; 1994 Oct; 56(2):262-73. PubMed ID: 7530253
[TBL] [Abstract][Full Text] [Related]
4. Site-specific IGFBP-1 hyper-phosphorylation in fetal growth restriction: clinical and functional relevance.
Abu Shehab M; Khosravi J; Han VK; Shilton BH; Gupta MB
J Proteome Res; 2010 Apr; 9(4):1873-81. PubMed ID: 20143870
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I.
Jones JI; D'Ercole AJ; Camacho-Hubner C; Clemmons DR
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7481-5. PubMed ID: 1715565
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of rat insulin-like growth factor binding protein-1 does not affect its biological properties.
Peterkofsky B; Gosiewska A; Wilson S; Kim YR
Arch Biochem Biophys; 1998 Sep; 357(1):101-10. PubMed ID: 9721188
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3.
Campbell PG; Durham SK; Suwanichkul A; Hayes JD; Powell DR
Am J Physiol; 1998 Aug; 275(2):E321-31. PubMed ID: 9688635
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
9. Identification of serines-1035/1037 in the kinase domain of the insulin receptor as protein kinase C alpha mediated phosphorylation sites.
Liu F; Roth RA
FEBS Lett; 1994 Oct; 352(3):389-92. PubMed ID: 7926007
[TBL] [Abstract][Full Text] [Related]
10. Physiological differences in insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation in IGFBP-1 transgenic mice.
Sakai K; D'Ercole AJ; Murphy LJ; Clemmons DR
Diabetes; 2001 Jan; 50(1):32-8. PubMed ID: 11147791
[TBL] [Abstract][Full Text] [Related]
11. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions.
Imai Y; Moralez A; Andag U; Clarke JB; Busby WH; Clemmons DR
J Biol Chem; 2000 Jun; 275(24):18188-94. PubMed ID: 10766744
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4.
Chernausek SD; Smith CE; Duffin KL; Busby WH; Wright G; Clemmons DR
J Biol Chem; 1995 May; 270(19):11377-82. PubMed ID: 7538115
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence.
Jones JI; Gockerman A; Busby WH; Wright G; Clemmons DR
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10553-7. PubMed ID: 7504269
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation.
Abu Shehab M; Iosef C; Wildgruber R; Sardana G; Gupta MB
Endocrinology; 2013 Mar; 154(3):1130-43. PubMed ID: 23354097
[TBL] [Abstract][Full Text] [Related]
15. Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3.
Dubaquié Y; Lowman HB
Biochemistry; 1999 May; 38(20):6386-96. PubMed ID: 10350456
[TBL] [Abstract][Full Text] [Related]
16. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
[TBL] [Abstract][Full Text] [Related]
17. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
18. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
[TBL] [Abstract][Full Text] [Related]
19. A mutant of human insulin-like growth factor II (IGF II) with the processing sites of proinsulin. Expression and binding studies of processed IGF II.
Zarn JA; Lüthi C; Giger RJ; Sigrist A; Humbel RE
Eur J Biochem; 1992 Dec; 210(3):665-9. PubMed ID: 1282887
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.
Cohen P; Peehl DM; Lamson G; Rosenfeld RG
J Clin Endocrinol Metab; 1991 Aug; 73(2):401-7. PubMed ID: 1713219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
